Genetic variants of the nonhomologous end joining gene LIG4 and severe radiation pneumonitis in nonsmall cell lung cancer patients treated with definitive radiotherapy
Open Access
Abstract
BACKGROUND: Nonhomologous end joining (NHEJ) is a pathway that repairs DNA double‐strand breaks (DSBs) to maintain genomic stability in response to irradiation. The authors hypothesized that single nucleotide polymorphisms (SNPs) in NHEJ repair genes may affect clinical outcomes in patients with nonsmall cell lung cancer (NSCLC) who receive definitive radio(chemo)therapy.METHODS: The authors genotyped 5 potentially functional SNPs—x‐ray repair complementing defective repair in Chinese hamster cells 4 (XRCC4) reference SNP (rs) number rs6869366 (−1394 guanine to thymine [−1394G→T] change) and rs28360071 (intron 3, deletion/insertion), XRCC5 rs3835 (guanine to adenine [G→A] change at nucleotide 2408), XRCC6 rs2267437 (−1310 cytosine to guanine [C→G) change], and DNA ligase IV (LIG4) rs1805388 (threonine‐to‐isoleucine change at codon 9 [T9I])—and estimated their associations with severe radiation pneumonitis (RP) (grade ≥3) in 195 patients with NSCLC.RESULTS: A predictive role in radiation pneumonitis (RP) development was observed for the LIG4 SNP rs1805388 (adjusted hazard ratio, 2.08; 95% confidence interval, 1.04‐4.12; P = .037 for the CT/TT genotype vs the CC genotype). In addition, men with the TT genotype of the XRCC4 rs6869366 SNP and women with AG + AA genotypes of the XRCC5 rs3835 SNP also were at increased risk of developing severe RP.CONCLUSIONS: The current results indicated that NHEJ genetic polymorphisms, particularly LIG4 rs1805388, may modulate the risk of RP in patients with NSCLC who receive definitive radio(chemo)therapy. Large studies will be needed to confirm these findings. Cancer 2011;. © 2011 American Cancer Society.Keywords
This publication has 20 references indexed in Scilit:
- Single Nucleotide Polymorphism at rs1982073:T869C of the TGFβ1 Gene Is Associated With the Risk of Radiation Pneumonitis in Patients With Non–Small-Cell Lung Cancer Treated With Definitive RadiotherapyJournal of Clinical Oncology, 2009
- Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end‐joining pathway genesCancer, 2009
- A novel single nucleotide polymorphism in XRCC4 gene is associated with oral cancer susceptibility in Taiwanese patientsOral Oncology, 2008
- Polymorphisms in nonhomologous end‐joining genes associated with breast cancer risk and chromosomal radiosensitivityGenes, Chromosomes and Cancer, 2007
- Transient depletion of Ku70 and Xrcc4 by RNAi as a means to manipulate the non-homologous end-joining pathwayJournal of Biotechnology, 2007
- Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non–small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Ku protein targeting by Ku70 small interfering RNA enhances human cancer cell response to topoisomerase II inhibitor and γ radiationMolecular Cancer Therapeutics, 2005
- Analysis of DNA ligase IV mutations found in LIG4 syndrome patients: the impact of two linked polymorphismsHuman Molecular Genetics, 2004
- DNA Ligase IV Mutations Identified in Patients Exhibiting Developmental Delay and ImmunodeficiencyMolecular Cell, 2001
- The Yield of DNA Double-strand Breaks Produced Intracellularly by Ionizing Radiation: A ReviewInternational Journal of Radiation Biology, 1990